Selected research
Industry Growth & Trends
Global Eubiotics Industry Growth and Trends Forecast to 2032
Market perspective
The global Eubiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Eubiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Eubiotics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Eubiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Eubiotics include YARA International Asa, SCC Holdings Berhad, Royal DSM, Kemin Industries, DuPont, Chr. Hansen A/S, Cargill Incorporated, Beneo Group and Behn Meyer Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Eubiotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Eubiotics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Eubiotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Eubiotics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Eubiotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Eubiotics Market by Company
YARA International Asa
SCC Holdings Berhad
Royal DSM
Kemin Industries
DuPont
Chr. Hansen A/S
Cargill Incorporated
Beneo Group
Behn Meyer Group
BASF SE
Eubiotics Segment by Type
Probiotics
Organic Acid
Eubiotics Segment by Application
Animals
Application 2
Eubiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eubiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eubiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eubiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eubiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Eubiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Probiotics
- Organic Acid
Applications
- Animals
- Application 2
Companies covered
- YARA International Asa
- SCC Holdings Berhad
- Royal DSM
- Kemin Industries
- DuPont
- Chr. Hansen A/S
- Cargill Incorporated
- Beneo Group
- Behn Meyer Group
- BASF SE
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Eubiotics Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Eubiotics Sales Estimates and Forecasts (2021-2032)
- 1.3 Eubiotics Market by Type
- 1.3.1 Probiotics
- 1.3.2 Organic Acid
- 1.4 Global Eubiotics Market Size by Type
- 1.4.1 Global Eubiotics Market Size Overview by Type (2021-2032)
- 1.4.2 Global Eubiotics Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Eubiotics Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Eubiotics Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Eubiotics Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Eubiotics Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Eubiotics Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Eubiotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Eubiotics Industry Trends
- 2.2 Eubiotics Industry Drivers
- 2.3 Eubiotics Industry Opportunities and Challenges
- 2.4 Eubiotics Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Eubiotics Revenue (2021-2026)
- 3.2 Global Top Players by Eubiotics Sales (2021-2026)
- 3.3 Global Top Players by Eubiotics Price (2021-2026)
- 3.4 Global Eubiotics Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Eubiotics Major Company Production Sites & Headquarters
- 3.6 Global Eubiotics Company, Product Type & Application
- 3.7 Global Eubiotics Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Eubiotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Eubiotics Players Market Share by Revenue in 2025
- 3.8.3 2025 Eubiotics Tier 1, Tier 2, and Tier 3
4 Eubiotics Regional Status and Outlook
- 4.1 Global Eubiotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Eubiotics Historic Market Size by Region
- 4.2.1 Global Eubiotics Sales in Volume by Region (2021-2026)
- 4.2.2 Global Eubiotics Sales in Value by Region (2021-2026)
- 4.2.3 Global Eubiotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Eubiotics Forecasted Market Size by Region
- 4.3.1 Global Eubiotics Sales in Volume by Region (2027-2032)
- 4.3.2 Global Eubiotics Sales in Value by Region (2027-2032)
- 4.3.3 Global Eubiotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Eubiotics by Application
- 5.1 Eubiotics Market by Application
- 5.1.1 Animals
- 5.1.2 Application 2
- 5.2 Global Eubiotics Market Size by Application
- 5.2.1 Global Eubiotics Market Size Overview by Application (2021-2032)
- 5.2.2 Global Eubiotics Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Eubiotics Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Eubiotics Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Eubiotics Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Eubiotics Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Eubiotics Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Eubiotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 YARA International Asa
- 6.1.1 YARA International Asa Company Information
- 6.1.2 YARA International Asa Business Overview
- 6.1.3 YARA International Asa Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 YARA International Asa Eubiotics Product Portfolio
- 6.1.5 YARA International Asa Recent Developments
- 6.2 SCC Holdings Berhad
- 6.2.1 SCC Holdings Berhad Company Information
- 6.2.2 SCC Holdings Berhad Business Overview
- 6.2.3 SCC Holdings Berhad Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 SCC Holdings Berhad Eubiotics Product Portfolio
- 6.2.5 SCC Holdings Berhad Recent Developments
- 6.3 Royal DSM
- 6.3.1 Royal DSM Company Information
- 6.3.2 Royal DSM Business Overview
- 6.3.3 Royal DSM Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Royal DSM Eubiotics Product Portfolio
- 6.3.5 Royal DSM Recent Developments
- 6.4 Kemin Industries
- 6.4.1 Kemin Industries Company Information
- 6.4.2 Kemin Industries Business Overview
- 6.4.3 Kemin Industries Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Kemin Industries Eubiotics Product Portfolio
- 6.4.5 Kemin Industries Recent Developments
- 6.5 DuPont
- 6.5.1 DuPont Company Information
- 6.5.2 DuPont Business Overview
- 6.5.3 DuPont Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 DuPont Eubiotics Product Portfolio
- 6.5.5 DuPont Recent Developments
- 6.6 Chr. Hansen A/S
- 6.6.1 Chr. Hansen A/S Company Information
- 6.6.2 Chr. Hansen A/S Business Overview
- 6.6.3 Chr. Hansen A/S Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Chr. Hansen A/S Eubiotics Product Portfolio
- 6.6.5 Chr. Hansen A/S Recent Developments
- 6.7 Cargill Incorporated
- 6.7.1 Cargill Incorporated Company Information
- 6.7.2 Cargill Incorporated Business Overview
- 6.7.3 Cargill Incorporated Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Cargill Incorporated Eubiotics Product Portfolio
- 6.7.5 Cargill Incorporated Recent Developments
- 6.8 Beneo Group
- 6.8.1 Beneo Group Company Information
- 6.8.2 Beneo Group Business Overview
- 6.8.3 Beneo Group Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Beneo Group Eubiotics Product Portfolio
- 6.8.5 Beneo Group Recent Developments
- 6.9 Behn Meyer Group
- 6.9.1 Behn Meyer Group Company Information
- 6.9.2 Behn Meyer Group Business Overview
- 6.9.3 Behn Meyer Group Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Behn Meyer Group Eubiotics Product Portfolio
- 6.9.5 Behn Meyer Group Recent Developments
- 6.10 BASF SE
- 6.10.1 BASF SE Company Information
- 6.10.2 BASF SE Business Overview
- 6.10.3 BASF SE Eubiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 BASF SE Eubiotics Product Portfolio
- 6.10.5 BASF SE Recent Developments
7 North America by Country
- 7.1 North America Eubiotics Sales by Country
- 7.1.1 North America Eubiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Eubiotics Sales by Country (2021-2026)
- 7.1.3 North America Eubiotics Sales Forecast by Country (2027-2032)
- 7.2 North America Eubiotics Market Size by Country
- 7.2.1 North America Eubiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Eubiotics Market Size by Country (2021-2026)
- 7.2.3 North America Eubiotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Eubiotics Sales by Country
- 8.1.1 Europe Eubiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Eubiotics Sales by Country (2021-2026)
- 8.1.3 Europe Eubiotics Sales Forecast by Country (2027-2032)
- 8.2 Europe Eubiotics Market Size by Country
- 8.2.1 Europe Eubiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Eubiotics Market Size by Country (2021-2026)
- 8.2.3 Europe Eubiotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Eubiotics Sales by Country
- 9.1.1 Asia-Pacific Eubiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Eubiotics Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Eubiotics Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Eubiotics Market Size by Country
- 9.2.1 Asia-Pacific Eubiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Eubiotics Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Eubiotics Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Eubiotics Sales by Country
- 10.1.1 South America Eubiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Eubiotics Sales by Country (2021-2026)
- 10.1.3 South America Eubiotics Sales Forecast by Country (2027-2032)
- 10.2 South America Eubiotics Market Size by Country
- 10.2.1 South America Eubiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Eubiotics Market Size by Country (2021-2026)
- 10.2.3 South America Eubiotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Eubiotics Sales by Country
- 11.1.1 Middle East and Africa Eubiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Eubiotics Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Eubiotics Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Eubiotics Market Size by Country
- 11.2.1 Middle East and Africa Eubiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Eubiotics Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Eubiotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Eubiotics Value Chain Analysis
- 12.1.1 Eubiotics Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Eubiotics Production Mode & Process
- 12.2 Eubiotics Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Eubiotics Distributors
- 12.2.3 Eubiotics Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst